
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immune classification of osteosarcoma
Trang Le, Sumeyye Su, Leili Shahriyari
Mathematical Biosciences & Engineering (2021) Vol. 18, Iss. 2, pp. 1879-1897
Open Access | Times Cited: 25
Trang Le, Sumeyye Su, Leili Shahriyari
Mathematical Biosciences & Engineering (2021) Vol. 18, Iss. 2, pp. 1879-1897
Open Access | Times Cited: 25
Showing 25 citing articles:
Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Hailong Tian, Jiangjun Cao, Bowen Li, et al.
Bone Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 106
Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications
Tianyi Zhu, Jing Han, Yang Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Tianyi Zhu, Jing Han, Yang Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74
Advances on immunotherapy for osteosarcoma
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 40
Shengnan Yu, Xudong Yao
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 40
Immune checkpoints in osteosarcoma: Recent advances and therapeutic potential
Wen Yang, Fan Tang, Chongqi Tu, et al.
Cancer Letters (2022) Vol. 547, pp. 215887-215887
Closed Access | Times Cited: 59
Wen Yang, Fan Tang, Chongqi Tu, et al.
Cancer Letters (2022) Vol. 547, pp. 215887-215887
Closed Access | Times Cited: 59
Decoding the Impact of Tumor Microenvironment in Osteosarcoma Progression and Metastasis
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 17
Bikesh K. Nirala, Taku Yamamichi, D. Isabel Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 5108-5108
Open Access | Times Cited: 17
Auxiliary Segmentation Method of Osteosarcoma in MRI Images Based on Denoising and Local Enhancement
Luna Wang, Yu Liao, Jun Zhu, et al.
Healthcare (2022) Vol. 10, Iss. 8, pp. 1468-1468
Open Access | Times Cited: 26
Luna Wang, Yu Liao, Jun Zhu, et al.
Healthcare (2022) Vol. 10, Iss. 8, pp. 1468-1468
Open Access | Times Cited: 26
Data-Driven Mathematical Model of Osteosarcoma
Trang Le, Sumeyye Su, Arkadz Kirshtein, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2367-2367
Open Access | Times Cited: 29
Trang Le, Sumeyye Su, Arkadz Kirshtein, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2367-2367
Open Access | Times Cited: 29
A Mathematical Model of Breast Tumor Progression Based on Immune Infiltration
Navid Mohammad Mirzaei, Sumeyye Su, Dilruba Sofia, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 1031-1031
Open Access | Times Cited: 26
Navid Mohammad Mirzaei, Sumeyye Su, Dilruba Sofia, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 10, pp. 1031-1031
Open Access | Times Cited: 26
A detoxified TLR4 agonist inhibits tumour growth and lung metastasis of osteosarcoma by promoting CD8+ cytotoxic lymphocyte infiltration
Ryunosuke Oyama, Akira Nabeshima, Makoto Endo, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
Ryunosuke Oyama, Akira Nabeshima, Makoto Endo, et al.
BJC Reports (2025) Vol. 3, Iss. 1
Open Access
Screening and identification Hub genes associated with immune cell infiltration and critical biomarkers in osteosarcoma
Xin Song, S Chen, Junning Cheng, et al.
Molecular and Cellular Probes (2025), pp. 102031-102031
Open Access
Xin Song, S Chen, Junning Cheng, et al.
Molecular and Cellular Probes (2025), pp. 102031-102031
Open Access
Immune pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma
Sunetra Das, Rupa Idate, Daniel P. Regan, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 19
Sunetra Das, Rupa Idate, Daniel P. Regan, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 19
Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer
Aparajita Budithi, Sumeyye Su, Arkadz Kirshtein, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2632-2632
Open Access | Times Cited: 18
Aparajita Budithi, Sumeyye Su, Arkadz Kirshtein, et al.
Cancers (2021) Vol. 13, Iss. 11, pp. 2632-2632
Open Access | Times Cited: 18
Five hypoxia and immunity related genes as potential biomarkers for the prognosis of osteosarcoma
Dachang Liu, Ziwei Hu, Jie Jiang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Dachang Liu, Ziwei Hu, Jie Jiang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Investigating Optimal Chemotherapy Options for Osteosarcoma Patients through a Mathematical Model
Trang Le, Sumeyye Su, Leili Shahriyari
Cells (2021) Vol. 10, Iss. 8, pp. 2009-2009
Open Access | Times Cited: 15
Trang Le, Sumeyye Su, Leili Shahriyari
Cells (2021) Vol. 10, Iss. 8, pp. 2009-2009
Open Access | Times Cited: 15
Identification of two immune subtypes in osteosarcoma based on immune gene sets
Mengkai Yang, Ya Cao, Zhuoying Wang, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107799-107799
Closed Access | Times Cited: 11
Mengkai Yang, Ya Cao, Zhuoying Wang, et al.
International Immunopharmacology (2021) Vol. 96, pp. 107799-107799
Closed Access | Times Cited: 11
Metastasis-Related Signature for Clinically Predicting Prognosis and Tumor Immune Microenvironment of Osteosarcoma Patients
Qing Zhang, Zhiping Deng, Yongkun Yang
Molecular Biotechnology (2023) Vol. 65, Iss. 11, pp. 1836-1845
Open Access | Times Cited: 4
Qing Zhang, Zhiping Deng, Yongkun Yang
Molecular Biotechnology (2023) Vol. 65, Iss. 11, pp. 1836-1845
Open Access | Times Cited: 4
Mathematical and Machine Learning Models of Renal Cell Carcinoma: A Review
Dilruba Sofia, Q. Zhou, Leili Shahriyari
Bioengineering (2023) Vol. 10, Iss. 11, pp. 1320-1320
Open Access | Times Cited: 4
Dilruba Sofia, Q. Zhou, Leili Shahriyari
Bioengineering (2023) Vol. 10, Iss. 11, pp. 1320-1320
Open Access | Times Cited: 4
Exploration of metastasis-related signatures in osteosarcoma based on tumor microenvironment by integrated bioinformatic analysis
Shiyao Liao, Xing Gao, Kai Zhou, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41358-e41358
Open Access | Times Cited: 1
Shiyao Liao, Xing Gao, Kai Zhou, et al.
Heliyon (2024) Vol. 11, Iss. 1, pp. e41358-e41358
Open Access | Times Cited: 1
Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells
Н. М. Тодосенко, K. А. Yurova, О. Г. Хазиахматова, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2181-2181
Open Access | Times Cited: 6
Н. М. Тодосенко, K. А. Yurova, О. Г. Хазиахматова, et al.
Pharmaceutics (2022) Vol. 14, Iss. 10, pp. 2181-2181
Open Access | Times Cited: 6
New gene signature from the dominant infiltration immune cell type in osteosarcoma predicts overall survival
Liping Gong, Xifeng Sun, Ming Jia
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Liping Gong, Xifeng Sun, Ming Jia
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Bio-Mechanical Model of Osteosarcoma Tumor Microenvironment: A Porous Media Approach
Yu Hu, Navid Mohammad Mirzaei, Leili Shahriyari
Cancers (2022) Vol. 14, Iss. 24, pp. 6143-6143
Open Access | Times Cited: 5
Yu Hu, Navid Mohammad Mirzaei, Leili Shahriyari
Cancers (2022) Vol. 14, Iss. 24, pp. 6143-6143
Open Access | Times Cited: 5
The mitochondrial energy metabolism pathway-related signature predicts prognosis and indicates immune microenvironment infiltration in osteosarcoma
Sen Yang, Liyun Liu, Xiaoyun Liu, et al.
Medicine (2023) Vol. 102, Iss. 46, pp. e36046-e36046
Open Access | Times Cited: 2
Sen Yang, Liyun Liu, Xiaoyun Liu, et al.
Medicine (2023) Vol. 102, Iss. 46, pp. e36046-e36046
Open Access | Times Cited: 2
Reprogramming tumor microenvironment via dual targeting co-delivery of regorafenib and alpha-difluoromethylornithine in osteosarcoma
Hongsheng Wang, Xinmeng Jin, Ying-Hua Gao, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Hongsheng Wang, Xinmeng Jin, Ying-Hua Gao, et al.
Cancer Nanotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Development and validation of an immune-related gene prognostic index for lung adenocarcinoma
Zitao Liu, Yujie Lei, Junting Shen, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 11, pp. 6205-6227
Open Access | Times Cited: 1
Zitao Liu, Yujie Lei, Junting Shen, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 11, pp. 6205-6227
Open Access | Times Cited: 1
Identification of Immune-Related Genes for Establishment of Prognostic Index in Hepatocellular Carcinoma
Yinfang Li, Ling Zou, Xuejun Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 1
Yinfang Li, Ling Zou, Xuejun Liu, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 1